Improving the Utility of a Dynorphin Peptide Analogue Using Mannosylated Glycoliposomes

Peptide therapeutics offer numerous advantages in the treatment of diseases and disorders of the central nervous system (CNS). However, they are not without limitations, especially in terms of their pharmacokinetics where their metabolic lability and low blood–brain barrier penetration hinder their...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewicky, Jordan D., Fraleigh, Nya L., Martel, Alexandrine L., Nguyen, Thi M.-D., Schiller, Peter W., Mousavifar, Leila, Roy, René, Le, Anh Dzung, Funk, Douglas, Le, Hoang-Thanh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348236/
https://www.ncbi.nlm.nih.gov/pubmed/34360762
http://dx.doi.org/10.3390/ijms22157996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348236/
https://www.ncbi.nlm.nih.gov/pubmed/34360762
http://dx.doi.org/10.3390/ijms22157996

Ejemplares similares